189
Bolt Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
173
FY23:
106
FY24:
50.8
FY25:
30.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
119
FY22:
55.1
FY23:
54.1
FY24:
48.8
FY25:
26.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
308
FY22:
228
FY23:
160
FY24:
99.6
FY25:
56.7
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
21.3
FY22:
23.1
FY23:
20.5
FY24:
15.9
FY25:
8.44
(negative)
Change from FY21 to FY25
millions USD
FY21:
36.3
FY22:
33.2
FY23:
26.6
FY24:
26.6
FY25:
21.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
250
FY22:
172
FY23:
113
FY24:
57.2
FY25:
26.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
308
FY22:
228
FY23:
160
FY24:
99.6
FY25:
56.7
All amounts in millions USD